decimmune.com
DecImmune Therapeutics : About : Overview
http://www.decimmune.com/about.html
Michael Carroll, PhD. Francis Moore, MD. Christopher K. Mirabelli, PhD. Walter Newman, PhD. Amgen Ventures, Astellas Venture Management and Broadview Ventures, in addition to $7 million in NIH SBIR grant funding. Research and Development Programs.
decimmunetherapeutics.com
DecImmune Therapeutics : About : Overview
http://www.decimmunetherapeutics.com/about.html
Michael Carroll, PhD. Francis Moore, MD. Christopher K. Mirabelli, PhD. Walter Newman, PhD. Amgen Ventures, Astellas Venture Management and Broadview Ventures, in addition to $7 million in NIH SBIR grant funding. Research and Development Programs.
mosaicbio.com
Board of Directors | Mosaic Biosciences
http://www.mosaicbio.com/board-of-directors
Nassim Usman, Ph.D. Venture Partner, Morgenthaler Ventures. Mark Lupa, Ph.D. Managing Director of High Country Ventures. With a Masters in Bioengineering and a PhD in Pharmacology, Dr. Lupa has a unique pedigree that includes 15 years medical research experience and being a Founder, former CEO, and CFO of Tabernash Brewing Company. In addition to his work with Mosaic Mark serves on several boards, including LeftHand/Tabernash, Oberon, TheraTogs, Surefire Medical, and Endoshape.
mosaicbio.com
Investors | Mosaic Biosciences
http://www.mosaicbio.com/investors
Mosaic Biosciences investors include:.
infacare.com
Investors | Infacare
http://www.infacare.com/investors
InfaCare is backed by premier group of venture capital firms. The Company was initially founded by WellSpring Pharmaceutical Corporation and funded by “angel” investors. In March 2006, InfaCare closed a $12 million Series A financing, and in October 2008 closed a $28 million Series B financing. The Company is currently raising a Series C financing to fund the completion of the current clinical trials. The principal investors in InfaCare are:.
vaxxas.com
Vaxxas - Investors
http://www.vaxxas.com/investors
Vaxxas Nanopatch™ Technology. OneVentures is a venture capital firm that invests in emerging Australian technology companies with true breakout potential, differentiated technology and compelling business models in the clean technology, information technology and life sciences sectors. Brandon Capital Partners makes seed and venture capital investments to support the development and international growth of Australian life science companies. We work collaboratively with entrepreneurs to demonstrate th...
theraclone-sciences.com
Theraclone Sciences /About/Investors
http://www.theraclone-sciences.com/investors.php
Alexandria Real Estate Equities. 1124 Columbia Street, Suite 300, Seattle, WA 98104 206.805.1600.
sidmartinbio.org
Investors
http://sidmartinbio.org/beta/investors
UF Sid Martin Biotech Institute. More than 34 investors from across the country have written checks to our companies. We guide our companies through the stressful fundraising process — from seed stage grant writing assistance, to the more mature Series C Round. Valuable feedback and investor introductions are provided by us. Sid Martin Biotech companies raise $24 million in average investment. Camulos Capital (H) / Cardinal Partners. Context Capital Mngt (H). Itera Int’l Energy Corp. Mark Long, Director.
shanghosh.wordpress.com
Top 100 Vcs | Shantanu Ghosh's Blog
https://shanghosh.wordpress.com/top-100-vcs
Shantanu Ghosh's Blog. 124; Comments RSS. Top European Software Cos. Top Performing Cos (UK). Top Startup Cos (UK). List of VCs (UK). Top early stage VCs (US). Top Angel Investors (US). Top Early stage VC cos (US). Ben Franklin Technology Partners Southeastern PA. Innovation Works, Inc. Ben Franklin Technology Partners of Northeastern PA. Kleiner Perkins Caufield and Byers. SV Life Sciences Advisers. Connecticut Innovations, Inc. North Bridge Venture Partners. Atlas Venture, Ltd. Tech Coast Angels, Inc.
cyberspaceinvestmentnews.blogspot.com
Cyberspace Investment News: June 2009
http://cyberspaceinvestmentnews.blogspot.com/2009_06_01_archive.html
The source for equity, debt and M&A deals. Sunday, June 28, 2009. Week of June 29. There will be no new posts for the week of June 29. Please come back and join me for more mergers, acquisition, equity and debt news beginning July 6. Have a great July 4th holiday. Friday, June 26, 2009. Cyberspace Investment News Friday June 26 Report. Good evening, this is Laura Speizman , Cyberspace Investment News, with the Friday June 26 report. This has been the Friday report. Good night. The Brazilian securities re...